These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9342369)

  • 1. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.
    Akhter SA; Skaer CA; Kypson AP; McDonald PH; Peppel KC; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12100-5. PubMed ID: 9342369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
    Drazner MH; Peppel KC; Dyer S; Grant AO; Koch WJ; Lefkowitz RJ
    J Clin Invest; 1997 Jan; 99(2):288-96. PubMed ID: 9005997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
    White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
    Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
    Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
    Anderson KM; Eckhart AD; Willette RN; Koch WJ
    Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.
    Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M
    Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.
    Eckhart AD; Koch WJ
    Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
    Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
    J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery.
    Maurice JP; Hata JA; Shah AS; White DC; McDonald PH; Dolber PC; Wilson KH; Lefkowitz RJ; Glower DD; Koch WJ
    J Clin Invest; 1999 Jul; 104(1):21-9. PubMed ID: 10393695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of beta-adrenergic signaling by gene transfer.
    Drazner MH; Koch WJ; Lefkowitz RJ
    Proc Assoc Am Physicians; 1997 May; 109(3):220-7. PubMed ID: 9154638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
    Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
    J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
    Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
    Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
    Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
    Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins.
    Kompa AR; Gu XH; Evans BA; Summers RJ
    J Mol Cell Cardiol; 1999 Jun; 31(6):1185-201. PubMed ID: 10371694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation.
    Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.